Association of multiple myeloma (MM) with different neoplasms (DN), including second primary malignancies (SPM): systematic analysis in consecutive patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003932

Enrollment

744

Registered

2015-05-28

Start date

2011-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C90

Interventions

Group 1: There are numerous innovations in treatment of multiple myeloma (MM), resulting in prolonged overall survival. Nevertheless, long-term complications may comprise the occurrence of different n

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with mulrtiple myeloma

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Prevalence of second malignancies in patients with multiple myeloma	—

Secondary

Measure	Time frame
Analysis of riskf factors and outcome	—

Countries

Germany

Contacts

Public ContactMonika Engelhardt Engelhardt

Uniklinik Freiburg

monika.engelhardt@uniklinik-freiburg.de+49 761 270 32460

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026